Email this article REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF DOMESTIC FLU-M INACTIVATED SPLIT INFLUENZA VACCINE FOR THE IMMUNIZATION OF ADULTS AGED BETWEEN 18 AND 60
- Authors: Feldblyum I.V.1, Subbotina K.A.1, Novgorodova S.D.1, Ignatev G.M.2, Alyeva M.K.1, Erofeeva M.K.3, Orlovsky V.G.4, Leneva I.A.5, Melnikov S.Y.6, Kazakova E.V.6, Nacharova E.P.6, Trukhin V.P.6
-
Affiliations:
- Vagner Perm State Medical University
- St. Petersburg Research Institute of Vaccines and Sera and the Bacterial Preparations Factory, Chumakov Federal Scientific Centre for Research and Development of Immunobiological Products
- Research Institute of Influenza, St. Petersburg
- Centre for Infections Ltd
- Mechnikov Research Institute of Vaccines and Sera
- St. Petersburg Research Institute of Vaccines and Sera and the Bacterial Preparations Factory
- Issue: Vol 95, No 5 (2018)
- Pages: 31-37
- Section: ORIGINAL RESEARCHES
- URL: https://microbiol.crie.ru/jour/article/view/305
- DOI: https://doi.org/10.36233/0372-9311-2018-5-31-37
- ID: 305
Cite item
Full Text
Abstract
About the authors
I. V. Feldblyum
Vagner Perm State Medical University
Author for correspondence.
Email: noemail@neicon.ru
Russian Federation
K. A. Subbotina
Vagner Perm State Medical University
Email: noemail@neicon.ru
Russian Federation
S. D. Novgorodova
Vagner Perm State Medical University
Email: noemail@neicon.ru
Russian Federation
G. M. Ignatev
St. Petersburg Research Institute of Vaccines and Sera and the Bacterial Preparations Factory, Chumakov Federal Scientific Centre for Research and Development of Immunobiological Products
Email: noemail@neicon.ru
Russian Federation
M. Kh. Alyeva
Vagner Perm State Medical University
Email: noemail@neicon.ru
Russian Federation
M. K. Erofeeva
Research Institute of Influenza, St. Petersburg
Email: noemail@neicon.ru
Russian Federation
V. G. Orlovsky
Centre for Infections Ltd
Email: noemail@neicon.ru
Russian Federation
I. A. Leneva
Mechnikov Research Institute of Vaccines and Sera
Email: noemail@neicon.ru
Russian Federation
S. Ya. Melnikov
St. Petersburg Research Institute of Vaccines and Sera and the Bacterial Preparations Factory
Email: noemail@neicon.ru
Russian Federation
E. V. Kazakova
St. Petersburg Research Institute of Vaccines and Sera and the Bacterial Preparations Factory
Email: noemail@neicon.ru
Russian Federation
E. P. Nacharova
St. Petersburg Research Institute of Vaccines and Sera and the Bacterial Preparations Factory
Email: noemail@neicon.ru
Russian Federation
V. P. Trukhin
St. Petersburg Research Institute of Vaccines and Sera and the Bacterial Preparations Factory
Email: noemail@neicon.ru
Russian Federation
References
- Бектимиров Т.А. Вакцинопрофилактика гриппа. Лечащий врач. 2005, 9. Доступен https://www.lvrach.ru/2005/09/4533051/.
- Медуницын Н.В. Вакцинология. М., Триада-X, 2010.
- Медуницын Н.В., Миронов А.Н., Мовсесян А.А. Теория и практика вакцинологии. М., Ремедиум, 2015.
- Грибкова Н.В., Шмелева Н.П. Ретроспективная оценка профилактики гриппа вакциной «Флюваксин» в постпандемические сезоны 2010-2013 годов в Республике Беларусь. Медицинские новости. 2014, 10: 50-52.
- Руководство по проведению клинических исследований лекарственных средств (иммунобиологические лекарственные препараты). Под ред. А.Н. Миронова. М., Гриф и К, 2012.
- Beran J., Prymula R., Chlibek R. et al. Evaluation of reactogenicity and immunogenicity of two influenza vaccines (vaxigrip and fluarix) in the season 1996-1997. Cent. Eur. J. Public Health. 1998, 6(4): 269-273.
- Beyer W., Palache A., Osterhaus A. Comparison of serology and reactogenicity between influensa subunit vaccines and whole virus or split vaccines: A review and metaanalysis of literature. Clin Drug Invest.1998,15(1):1-12.
- Bricout H., Chabanon Al., Souverain A. et al. Passive enhanced safety surveillance for Vaxigrip and Intanza 15 pg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16. Euro Surveill. 2017, 22(18): 1-9.
- Gessner B.D. et al. Seasonal influenza epidemiology in sub-Saharan Africa: a systematic review. Lancet Infectious Disease. 2011,11:223-235.
- Vaccines against influenza WHO position paper. November 2012. Wkly Epidemiol. Rec. 2012, 87(47):461-76. PMID: 23210147.
Supplementary files
